Tumor suppressor gene co-operativity in compound patched1 and suppressor of fused heterozygous mutant mice

Molecular Carcinogenesis

Volumn 48, Issue 5, 2009, Pages 408-419

  Svärd, Jessica ^a   Rozell, Björn ^b   Toftgård, Rune ^a   Teglund, Stephan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Basal cell carcinoma; Hedgehog proteins; Hydrocephalus; Pancreas cyst; Rhabdomyosarcoma

Indexed keywords

PROTEIN; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; SUPPRESSOR OF FUSED PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; PATCHED RECEPTORS; REPRESSOR PROTEIN; SUFU PROTEIN, HUMAN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; FEEDBACK SYSTEM; FEMALE; GENE INTERACTION; HETEROZYGOSITY; HETEROZYGOTE; HYDROCEPHALUS; MALE; MEDULLOBLASTOMA; MORBIDITY; MOUSE; MUTANT; NEGATIVE FEEDBACK; NONHUMAN; PANCREAS CYST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE; UPREGULATION; WILD TYPE; ANIMAL; GENETICS; IMMUNOHISTOCHEMISTRY; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ERINACEIDAE; MUS;

ANIMALS; FEMALE; GENES, TUMOR SUPPRESSOR; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65649084121     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20479     Document Type: Article

References (33)

1. Rohatgi R, Scott MP. Patching the gaps in Hedgehog signalling. Nat Cell Biol 2007;9:1005-1009. (Pubitemid 47338138)
2. Ingham PW, Placzek M. Orchestrating ontogenesis: Variations on a theme by sonic hedgehog. Nat Rev Genet 2006; 7:841-850.
3. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003;3: 903-911. (Pubitemid 37500175)
4. Ingham PW, McMahon AP. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001; 15:3059-3087.
5. Kogerman P, Grimm T, Kogerman L, et al. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol 1999;1:312-319.
6. Svard J, Heby-Henricson K, Persson-Lek M, et al. Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 2006;10:187-197.
7. Cooper AF, Yu KP, Brueckner M, et al. Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused. Development 2005;132:4407-4417.
8. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997;277:1109-1113. (Pubitemid 27371635)
9. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998;4:619-622. (Pubitemid 28237364)
10. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-851.
11. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004;6:530-539. (Pubitemid 39576548)
12. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-1671.
13. Polkinghorn WR, Tarbell NJ. Medulloblastoma: Tumori- genesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol 2007;4:295-304. (Pubitemid 46758787)
14. Hahn H, Wojnowski L, Specht K, et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem 2000;275:28341-28344.
15. Wetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001;61:513-516. (Pubitemid 32128609)
16. Lee Y, Kawagoe R, Sasai K, et al. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 2007.
17. Aszterbaum M, Epstein J, Oro A, etal. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999;5: 1285-1291.
18. Milenkovic L, Goodrich LV, Higgins KM, Scott MP. Mouse patched1 controls body size determination and limb patterning. Development 1999;126:4431-4440.
19. Wetmore C, Eberhart DE, Curran T. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res 2000;60:2239-2246. (Pubitemid 30225189)
20. Berman DM, Karhadkar SS, Hallahan AR, et al. Medullo- blastoma growth inhibition byhedgehog pathwayblockade. Science 2002;297:1559-1561.
21. Oliver TG, Read TA, Kessler JD, et al. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 2005;132:2425-2439.
22. Romer JT, Kimura H, Magdaleno S, et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004;6:229-240.
23. Lee Y, Miller HL, Russell HR, Boyd K, Curran T, McKinnon PJ. Patched2 modulates tumorigenesis in patched1 heterozygous mice. Cancer Res 2006;66:6964-6971. (Pubitemid 44197671)
24. Pazzaglia S, Mancuso M, Atkinson MJ, et al. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene 2002;21:7580-7584.
25. Pazzaglia S, Tanori M, Mancuso M, et al. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice. Oncogene 2006;25:5575-5580.
26. Magdaleno S, Jensen P, Brumwell CL, etal. BGEM: An in situ hybridization database of gene expression in the embryonic and adult mouse nervous system. PLoS Biol 2006;4:e86.
27. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002;31:306-310.
28. Koch A, Waha A, Hartmann W, et al. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours. Neuropathol Appl Neurobiol 2004;30:532-539.
29. Adolphe C, Hetherington R, Ellis T, Wainwright B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 2006;66:2081-2088. (Pubitemid 43294917)
30. Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgard R, Unden AB. Deregulation of the hedgehog signalling pathway: A possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 2006;208:17-25.
31. Mao J, Ligon KL, Rakhlin EY, et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 2006;66:10171-10178.
32. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-856.
33. Dagg C. Green E, editor. Teratogenesis. Biology of the laboratory mouse. New York: McGraw-Hill; 1966.